Washington University in St. Louis, Department of Biomedical Engineering, St. Louis, Missouri, United States.
California Institute of Technology, Caltech Optical Imaging Laboratory, Andrew and Peggy Cherng Depa, United States.
J Biomed Opt. 2020 Mar;25(3):1-17. doi: 10.1117/1.JBO.25.3.036002.
Detection and characterization of circulating tumor cells (CTCs), a key determinant of metastasis, are critical for determining risk of disease progression, understanding metastatic pathways, and facilitating early clinical intervention.
We aim to demonstrate label-free imaging of suspected melanoma CTCs.
We use a linear-array-based photoacoustic tomography system (LA-PAT) to detect melanoma CTCs, quantify their contrast-to-noise ratios (CNRs), and measure their flow velocities in most of the superficial veins in humans.
With LA-PAT, we successfully imaged suspected melanoma CTCs in patients in vivo, with a CNR >9. CTCs were detected in 3 of 16 patients with stage III or IV melanoma. Among the three CTC-positive patients, two had disease progression; among the 13 CTC-negative patients, 4 showed disease progression.
We suggest that LA-PAT can detect suspected melanoma CTCs in patients in vivo and has potential clinical applications for disease monitoring in melanoma.
循环肿瘤细胞 (CTC) 的检测和特征分析是转移的关键决定因素,对于确定疾病进展的风险、了解转移途径以及促进早期临床干预至关重要。
我们旨在展示疑似黑色素瘤 CTC 的无标记成像。
我们使用基于线阵的光声层析成像系统 (LA-PAT) 来检测黑色素瘤 CTC,定量其对比噪声比 (CNR),并测量它们在大多数人体浅表静脉中的血流速度。
通过 LA-PAT,我们成功地对体内疑似黑色素瘤 CTC 进行了成像,其 CNR 大于 9。在 3 期或 4 期黑色素瘤的 16 名患者中检测到了 CTC。在 3 名 CTC 阳性患者中,有 2 人出现疾病进展;在 13 名 CTC 阴性患者中,有 4 人出现疾病进展。
我们建议 LA-PAT 可以在体内检测疑似黑色素瘤 CTC,并有可能在黑色素瘤的疾病监测中得到临床应用。